International Journal of Trichology International Journal of Trichology
 Print this page Email this page Small font sizeDefault font sizeIncrease font size
  Home | About IJT | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions | Online submission | Subscribe | Advertise | Contact us | Login   

    Article Cited by others


Finasteride induced gynecomastia: Case report and review of the literature

Ramot Yuval, Czarnowicki Tali, Zlotogorski Abraham

Year : 2009| Volume: 1| Issue : 1 | Page no: 27-29

   This article has been cited by
1 The Androgenic Alopecia Protective Effects of Forsythiaside-A and the Molecular Regulation in a Mouse Model
Heon-Sub Shin,Sang-Yong Park,Hyun-Geun Song,Eunson Hwang,Don-Gil Lee,Tae-Hoo Yi
Phytotherapy Research. 2015; : n/a
[Pubmed]  [Google Scholar] [DOI]
2 Gynecomastia and drugs: a critical evaluation of the literature
Frank Q. Nuttall,Rohit S. Warrier,Mary C. Gannon
European Journal of Clinical Pharmacology. 2015; 71(5): 569
[Pubmed]  [Google Scholar] [DOI]
3 5a-Reductase inhibitors in androgenetic alopecia
Elizabeth Yim,Katherine L. Baquerizo Nole,Antonella Tosti
Current Opinion in Endocrinology & Diabetes and Obesity. 2014; 21(6): 493
[Pubmed]  [Google Scholar] [DOI]
4 Drug-Induced Gynecomastia
John D. Bowman,Hyunah Kim,Juan J. Bustamante
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2012; 32(12): 1123
[Pubmed]  [Google Scholar] [DOI]
5 Drug-induced gynecomastia
Bowman, J.D. and Kim, H. and Bustamante, J.J.
Pharmacotherapy. 2012; 32(12): 1123-1140
[Pubmed]  [Google Scholar]
6 Topical melatonin for treatment of androgenetic alopecia
Fischer, T. and Trüeb, R. and Hänggi, G. and Innocenti, M. and Elsner, P.
International Journal of Trichology. 2012; 4(4): 236-245
[Pubmed]  [Google Scholar]
7 Topical melatonin for treatment of androgenetic alopecia [Melatonin in der topischen Behandlung der androgenetischen Alopezie]
Fischer, T.W. and Trüeb, R.M. and Hänggi, G. and Innocenti, M. and Elsner, P.
Aktuelle Dermatologie. 2011; 37(11): 410-418
[Pubmed]  [Google Scholar]
8 Steroid 5α-reductase as a novel therapeutic target for schizophrenia and other neuropsychiatric disorders
Paba, S. and Frau, R. and Godar, S.C. and Devoto, P. and Marrosu, F. and Bortolato, M.
Current Pharmaceutical Design. 2011; 17(2): 151-167
[Pubmed]  [Google Scholar]


Read this article